A CDSCO medical device test license is a mandatory regulatory authorisation under India's Medical Devices Rules, 2017 that permits a manufacturer or importer to produce or import small quantities of a medical device solely for testing, clinical investigation, evaluation, demonstration, and training — not for commercial sale. There are two types: Form MD-13 (test license to manufacture — applied for via Form MD-12) and Form MD-17 (test license to import — applied for via Form MD-16). Both are issued by the State Licensing Authority through the CDSCO SUGAM online portal. The test license is typically valid for 3 years and can be extended. It covers all classes of medical devices (Class A through D). It is a critical regulatory precursor for first-time manufacturers who need to produce the three consecutive batch Certificate of Analysis reports required for a permanent MD5 or MD9 manufacturing license application.
Under India's Medical Devices Rules, 2017, even a single batch of a notified medical device cannot be manufactured at an Indian facility or imported into India for evaluation purposes without the appropriate regulatory authorisation. This is not a widely appreciated constraint — many manufacturers discovering CDSCO's requirements for the first time assume that small-scale testing activity falls outside the licensing framework. It does not. The test license requirement under MDR 2017 is absolute: the device category, the quantity, and the intent are all immaterial. Without a valid test license, the manufacture or import of any notified medical device for any purpose is not lawful.
The CDSCO medical device test license — issued as Form MD-13 for manufacturing activities and Form MD-17 for import activities — exists precisely to accommodate this pre-commercial regulatory need. It creates a structured, supervised pathway for manufacturers and importers to evaluate their devices, conduct clinical investigations, train their teams, and generate the technical data required for permanent CDSCO licensing — all within a regulatory framework that CDSCO can monitor and that provides accountability for how the licensed quantities are used.
📑 Quick Navigation
- What Is a CDSCO Medical Device Test License?
- The Two Types: MD13 (Manufacture) vs MD17 (Import)
- Why the Test License Is Needed — and Why It Matters Strategically
- Test License in the Route to Permanent CDSCO Licensing
- Mandatory Documents for CDSCO Test License
- 5-Step Application Process Through CDSCO SUGAM
- Validity, Extension, and Post-Testing Transition
- 5 Benefits of the CDSCO Medical Device Test License
- How Rego Services Supports Your Test License Application
- Frequently Asked Questions
What Is a CDSCO Medical Device Test License?
A CDSCO medical device test license is a regulatory authorisation granted under Rule 37 of the Medical Devices Rules, 2017 that permits an organisation to manufacture or import a defined, limited quantity of a notified medical device for purposes that are strictly restricted to clinical investigation, safety and performance evaluation, demonstration, testing, and training. The license explicitly prohibits the use of devices manufactured or imported under its authority for commercial sale.
The test license framework recognises a practical reality in medical device development and market entry: companies need to be able to evaluate their devices under real-world conditions, generate technical data for regulatory submissions, and train their teams — all of which require access to physical device units before a permanent manufacturing or import license is in place. The test license provides the legal mechanism for this activity while maintaining CDSCO's visibility and control over the quantities involved and the purposes for which they are used.
The Two Types: MD13 (Manufacture) vs MD17 (Import)
CDSCO issues two distinct forms of medical device test license — one for organisations that will manufacture devices in India and one for organisations that will import devices from outside India for testing purposes. The choice between them is straightforward and determined entirely by where the devices will be produced.
Why the Test License Is Needed — and Why It Matters Strategically
The immediate reason for needing a CDSCO test license is legal compliance — without it, any manufacture or import of a notified medical device is unlawful under MDR 2017, regardless of the intent or quantity involved. But beyond the compliance imperative, the test license serves several strategically important functions in a medical device company's India market entry plan.
A Certificate of Analysis for three consecutive production batches is a mandatory document for CDSCO MD5 and MD9 permanent manufacturing license applications. For a first-time manufacturer with no existing licensed production, these batches cannot be lawfully produced without an MD13 test license. The test license is therefore not optional — it is the legally required mechanism for generating the technical data that a permanent manufacturing license application cannot proceed without.
Medical device companies entering India frequently need to conduct clinical investigations to generate India-specific safety and efficacy data — either as a condition of their CDSCO submission or to build the clinical evaluation file required for their Device Master File. The test license provides the authorised framework within which clinical investigation units can be manufactured or imported and supplied to investigation sites without requiring a full permanent license.
Device companies often need to demonstrate their products to hospital procurement teams, key opinion leaders, and distributors before commercial launch — to build clinical relationships, gather feedback, and develop their Indian commercial pipeline in parallel with the regulatory process. The test license permits imports or manufacturing specifically for demonstration purposes, enabling market development activity to proceed within a lawful regulatory framework.
Before a manufacturer begins commercial production, their assembly, testing, and quality control teams need hands-on training with actual device units to build operational competency. The test license explicitly permits manufacture for training purposes — allowing companies to develop team capability and refine their manufacturing processes before the permanent licensing audit, when process consistency and staff competency will both be assessed.
Test License in the Route to Permanent CDSCO Licensing
The CDSCO test license is not a standalone regulatory endpoint — it is an intermediate step in the structured pathway from planning to permanent commercial authorisation. Understanding where the test license sits in that pathway helps manufacturers plan realistic timelines and avoid the delays that arise from discovering the test license requirement only after the permanent license application is underway.
Certification
Application
(MD-12 or MD-16)
Granted
or Import
Small Batches
of Analysis
MD5 / MD9 / MD15
ISO 13485 Certification in India 2026 — Complete Guide
ISO 13485 certification is a mandatory document for the CDSCO test license application — and for all subsequent permanent license applications. This guide explains all 8 clauses, the 10-step certification process, and how Rego Services supports manufacturers through gap analysis, QMS documentation, and certification body audit preparation.
Mandatory Documents for CDSCO Medical Device Test License
The document requirements for a CDSCO test license application are defined under the Medical Devices Rules, 2017 and the associated CDSCO guidance. The list is less extensive than a permanent manufacturing license application, but the quality and completeness of each document matters — the State Licensing Authority reviews submissions carefully and will raise queries on incomplete or inconsistent documents, extending the application timeline. The following documents are required across both MD-12 (manufacture) and MD-16 (import) test license applications.
- Device description — A clear, technically accurate description of the medical device covering its intended purpose, design characteristics, materials of construction, physical specifications, and the mechanism by which it achieves its intended effect. The description must be precise enough for CDSCO reviewers to confirm the device's classification and the relevance of the proposed testing programme.
- ISO 13485 certificate — A current, in-scope ISO 13485 certificate from an IAF-accredited certification body. The certificate must cover the manufacturing or quality management activities relevant to the declared device. This is a mandatory hard requirement — the test license application will not proceed without it.
- Undertaking on restricted end-use — A signed declaration from the applicant confirming that all devices manufactured or imported under the test license will be used exclusively for the permitted purposes — clinical investigation, evaluation, testing, demonstration, or training — and will not be sold commercially.
- Quantity justification statement — A written justification for the quantity of devices proposed for manufacture or import under the test license. The quantity must be proportionate to the testing plan — CDSCO will query applications where the proposed quantity appears excessive relative to the stated testing need.
- Detailed testing or investigation plan — For devices intended for clinical investigation, a detailed plan specifying the tests to be conducted, the number of patients or subjects involved, the study sites, the study duration, the primary and secondary endpoints, and the methodology for data collection and analysis. For non-clinical testing (performance evaluation, demonstration), a clear description of the testing programme and how the results will be used.
- Testing site and facility declaration — Identification of the specific sites where clinical investigations, demonstrations, evaluations, testing, or training will be conducted. Where the testing will be conducted at an external laboratory or clinical site, an undertaking from that facility confirming the availability of the required infrastructure and personnel must be included.
- Testing facility undertaking — A formal written undertaking from each laboratory or testing facility where device testing or clinical investigation will be conducted, confirming the facility's availability, infrastructure, and commitment to participate in the testing programme as described in the testing plan.
- Device labelling and Instructions for Use (IFU) — Draft labelling for the device including the device name, manufacturer details, lot/batch number, intended use, applicable warnings, precautions, and contraindications. The Instructions for Use must be complete and consistent with the device description and testing plan. Labelling for test license devices must clearly indicate that the device is for testing and evaluation purposes only and not for commercial sale.
- Quality certificate or relevant quality documentation — Supporting quality documentation relevant to the device — which may include relevant test standards compliance data, material specifications, or biocompatibility summary where applicable to the device type.
5-Step Application Process Through CDSCO SUGAM
CDSCO test license applications are submitted and processed entirely through the CDSCO SUGAM online portal (cdscoonline.gov.in). All document uploads, fee payments, query responses, and license grants are managed through this platform. The process follows five structured steps.
Create a company account at cdscoonline.gov.in or log in to an existing account. Ensure that the entity details registered on the portal — legal name, registered address, GST number, and contact information — exactly match the identity documents being submitted with the application. Discrepancies between portal registration details and supporting documents are a common source of early-stage application rejections.
Select Form MD-12 on the SUGAM portal if applying for a test license to manufacture medical devices. Select Form MD-16 if applying for a test license to import medical devices. The form selection determines the document fields that will be displayed and the fee structure that will apply. Selecting the wrong form requires the application to be restarted. The license issued will correspond to the application form selected: MD-13 for manufacture (Form MD-12) and MD-17 for import (Form MD-16).
Upload all required documents through the SUGAM portal in the specified file formats. Each document must be clearly labelled and consistent with the information declared in the application form. The testing plan, quantity justification, and testing site declarations require the most careful preparation — these are the documents most likely to generate reviewer queries. Ensure the ISO 13485 certificate uploaded is current and its scope covers the manufacturing or quality management activities relevant to the device.
Pay the applicable government fee for the test license application through the SUGAM portal's integrated payment system. The fee is determined by the device class and the license type. Retain the digital payment receipt and the application reference number. The application is formally submitted on payment completion — prior to payment, the application remains in draft status and has not been received by the reviewing authority.
The State Licensing Authority reviews the application and supporting documents. If all criteria are satisfied and no queries are raised, the test license is issued through the SUGAM portal — Form MD-13 for manufacture, Form MD-17 for import. If queries are raised, they must be addressed through the portal within the specified timeframe. Thorough initial document preparation is the most effective way to minimise the query cycle and shorten the time from submission to license grant.
Validity, Extension, and Post-Testing Transition
Understanding the validity rules for the CDSCO test license — and planning the transition to permanent licensing before that validity period expires — is an important part of managing the regulatory timeline effectively.
| Parameter | Detail |
|---|---|
| Standard validity period | 3 years from the date of grant, subject to continued compliance with MDR 2017 conditions |
| Validity variations | May be shorter or longer depending on device type, complexity of the testing plan, and CDSCO's assessment at time of grant |
| Extension eligibility | Available where testing is not completed within the original validity period — must be applied for before the license expires |
| Extension application timing | Applications submitted after license expiry may not be accepted — maintain a compliance calendar with the expiry date and apply for extension with adequate lead time |
| Post-testing transition | Once testing, evaluation, and clinical investigation are satisfactorily completed, the applicant may apply for the permanent manufacturing license (MD5 or MD9) or import license (MD15) |
| Permitted activities under test license | Clinical investigation, safety and performance evaluation, testing, demonstration, training — not commercial sale |
The most common timeline management mistake is treating the test license and the permanent manufacturing license as sequential processes — waiting for the test license to be fully utilised and testing data collected before beginning permanent license preparation. In practice, the two processes should run on partially overlapping tracks. ISO 13485 certification (required for both), Plant Master File preparation, and Device Master File drafting can all begin during the test license validity period, so that when the Certificate of Analysis for three consecutive batches is ready, the permanent license application dossier is already substantially complete.
5 Benefits of the CDSCO Medical Device Test License
The test license is the only lawful mechanism for manufacturing or importing a notified medical device in India before a permanent license is granted. Operating without it — even for a single batch intended solely for internal testing — exposes the company to regulatory enforcement under the Drugs and Cosmetics Act. The test license converts pre-commercial device activity from a regulatory risk to a managed, supervised process.
Clinical evaluation data is increasingly scrutinised in CDSCO permanent license applications, particularly for Class C and D devices. The test license provides the regulatory framework within which clinical investigations can be lawfully conducted in India — generating India-specific clinical data that strengthens the permanent license application and builds the evidence base for the Device Master File's clinical evaluation section.
Medical devices imported without a valid CDSCO authorisation face significant challenges at Indian customs — including detention, seizure, and return of goods. A valid MD17 test license provides the documentary authorisation that customs authorities require to clear imported device quantities for evaluation purposes, preventing expensive and time-consuming customs issues that can disrupt testing programmes and extend timelines.
The Certificate of Analysis for three consecutive production batches — produced under the MD13 test license — is a mandatory document for MD5 and MD9 permanent manufacturing license applications. Without the test license, this data cannot be lawfully generated. The test license is therefore the critical enabling step for first-time manufacturers, and completing it efficiently — with well-documented batch records — directly accelerates the permanent licensing timeline.
The test license permits the use of manufactured or imported device units for training of manufacturing, quality, clinical, and commercial teams, and for product demonstrations to prospective hospital customers, distributors, and key opinion leaders. This allows companies to build operational readiness and commercial relationships before the permanent license is in place — so that commercial launch can begin promptly once the permanent license is granted.
Dermatological and Plastic Surgery Medical Devices — CDSCO Registration Guide 2026
If your device is in the dermatological or plastic surgery category, this guide covers CDSCO classification across Class A to D, the applicable permanent licensing pathways (MD5, MD9, MD15), and how the test license fits into your India registration strategy for this device category.
How Rego Services Supports Your Test License Application
Rego Services Private Limited provides end-to-end support for CDSCO medical device test license applications — both MD13 (manufacture) and MD17 (import) — across all device categories and all classes. Our support is designed to produce applications that are complete, technically accurate, and structured to minimise queries from the State Licensing Authority, compressing the time from submission to license grant.
- Device classification and test license strategy — We confirm the CDSCO classification of your device, advise on whether an MD13 or MD17 test license (or both) is required for your specific situation, and build a test license timeline coordinated with your ISO 13485 certification and permanent licensing targets.
- ISO 13485 certification support — If ISO 13485 certification is not yet in place, we support the full certification process — gap analysis, QMS documentation, implementation, internal audit, and certification body liaison — on a timeline that does not delay the test license application submission date.
- Testing plan development — We help you develop a detailed, CDSCO-acceptable testing or clinical investigation plan that specifies all required parameters — test methodology, quantities, sites, patient or subject numbers, duration, and endpoints — reducing the likelihood of a query on this frequently challenged document.
- Quantity justification preparation — We prepare the quantity justification statement with the level of technical specificity that CDSCO reviewers expect, linking the proposed quantity directly to the defined testing needs in a way that is transparent and defensible.
- Complete document set preparation — We prepare the full set of test license application documents — device description, undertaking on end-use, labelling and IFU drafts, testing site declarations, and testing facility undertakings — in formats consistent with CDSCO requirements and the SUGAM portal's submission specifications.
- SUGAM portal submission management — We manage the online application submission process through the CDSCO SUGAM portal, ensuring documents are uploaded correctly, the right form is selected, fees are paid, and the application is formally submitted without procedural errors.
- Query response support — Where the State Licensing Authority raises queries, we draft and coordinate responses that directly address the reviewer's specific concern, drawing on our experience of common test license query patterns to provide clear, evidence-based replies that move the review forward.
- Post-grant compliance and transition to permanent licensing — We support ongoing compliance with test license conditions, validity monitoring, extension applications where required, and the transition from test license to permanent manufacturing or import license — ensuring continuity in your regulatory programme and no gaps in CDSCO authorisation status.
Frequently Asked Questions
Can one test license cover multiple device models?
The test license covers the specific device or devices declared in the application. If you need to test multiple device models, each model must be included in the application with its own device description, quantity justification, and testing plan. Where multiple devices are closely related — for example, different size variants of the same device family — a single application may be possible if the testing plan coherently addresses all variants. Rego Services advises on the most efficient application structure for multi-device test license situations.
Is a separate ISO 13485 certificate needed for the test license if we already have one for another product?
The existing ISO 13485 certificate can be used for the test license application provided its scope covers the manufacturing or quality management activities relevant to the device being tested. If the certificate scope is limited to a specific product family that does not include the test device, the scope may need to be extended before the test license application is submitted. Rego Services reviews the existing certificate scope as part of test license readiness assessment.
What happens if devices manufactured or imported under the test license are found to have been sold commercially?
Commercial sale of devices manufactured or imported under a CDSCO test license is a violation of both the license conditions and the Medical Devices Rules, 2017. This can result in cancellation of the test license, regulatory enforcement action under the Drugs and Cosmetics Act, and potentially adverse consequences for any subsequent permanent license applications. The undertaking on restricted end-use signed as part of the application is a binding commitment — it should be supported by internal controls to ensure all test license units are tracked and accounted for throughout their lifecycle.
Can a foreign manufacturer apply for an MD17 test import license directly, or is an Indian entity required?
An Indian entity — either the foreign manufacturer's Indian subsidiary, a registered Indian importer, or an authorised Indian agent — must hold the MD17 test import license. The license is granted to an Indian-registered entity that takes regulatory responsibility for the imported devices in India. Foreign manufacturers without an established Indian presence typically need to appoint an Indian authorised agent or establish a local entity before the test import license application can be filed.
Does the CDSCO test license cover devices used in clinical trials under the Clinical Trials Rules?
The CDSCO medical device test license covers the manufacture or import of devices for clinical investigation, evaluation, and testing under MDR 2017. Where a clinical investigation falls within the definition of a clinical trial under the New Drugs and Clinical Trials Rules, 2019 — which may apply for certain higher-risk device investigations — separate clinical trial approval from CDSCO may be required in addition to the test license. Rego Services advises on whether your specific investigation requires dual authorisation and coordinates both application tracks where needed.
✓ Key Takeaways
- A CDSCO medical device test license is a mandatory regulatory requirement under MDR 2017 for any manufacture or import of a notified medical device for testing, evaluation, clinical investigation, demonstration, or training — with no exemptions based on quantity or device class
- There are two distinct types: Form MD-13 (test license to manufacture — applied via Form MD-12) and Form MD-17 (test license to import — applied via Form MD-16), both issued by the State Licensing Authority
- The test license covers all classes of medical devices — Class A, B, C, and D — and permits clinical investigation, evaluation, testing, demonstration, and training only, not commercial sale
- A valid ISO 13485 certificate is a mandatory document for the test license application — this means ISO 13485 certification must be in place before the test license application can be submitted
- For first-time manufacturers, the MD13 test license is the legally required mechanism for producing the three consecutive batch Certificate of Analysis reports that are mandatory for a permanent MD5 or MD9 manufacturing license application
- The test license is typically valid for 3 years — extensions must be applied for before the original validity period expires; applications after expiry may not be accepted
- Applications are submitted through the CDSCO SUGAM portal in 5 structured steps from portal registration to license grant
- Permanent licensing preparation — ISO 13485 certification, Plant Master File, and Device Master File — should proceed on a parallel track during the test license period, not sequentially after it, to compress overall time to commercial launch
Your Next Step
The CDSCO medical device test license is frequently an underestimated element of the India regulatory pathway — treated as a minor procedural step rather than the strategically important authorisation it actually is. For first-time manufacturers, it is the legal gateway to generating the technical data on which the permanent manufacturing license application depends. For importers, it is the regulatory mechanism that enables evaluation-stage market development activity without risking customs enforcement. Getting it right — with complete documents, a well-constructed testing plan, and a quantity justification that survives reviewer scrutiny — sets the tone for the permanent licensing applications that follow.
Rego Services' regulatory team has supported medical device companies across India through CDSCO test license applications for a wide range of device categories — from low-risk Class A consumables to Class C active devices. Our approach combines rigorous document preparation with an understanding of what State Licensing Authority reviewers actually examine in test license applications, enabling us to prepare submissions that are complete, consistent, and structured to move through the review process without unnecessary delay.
Contact Rego Services today to discuss your CDSCO medical device test license requirements and receive a clear, timeline-specific plan for your application.